Aug 25, 2019
CEO named for first UPMC Enterprises’ Translational Sciences spin-out
BlueSphere Bio, the first company to spin out of UPMC Enterprises’ Translational Sciences focus area, has named industry veteran David Apelian, MD, PhD, MBA, as the company’s CEO.
